Literature DB >> 18772877

A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing.

Christopher G Pierce1, Priya Uppuluri, Amanda R Tristan, Floyd L Wormley, Eilidh Mowat, Gordon Ramage, Jose L Lopez-Ribot.   

Abstract

The incidence of fungal infections has increased significantly over the past decades. Very often these infections are associated with biofilm formation on implanted biomaterials and/or host surfaces. This has important clinical implications, as fungal biofilms display properties that are dramatically different from planktonic (free-living) populations, including increased resistance to antifungal agents. Here we describe a rapid and highly reproducible 96-well microtiter-based method for the formation of fungal biofilms, which is easily adaptable for antifungal susceptibility testing. This model is based on the ability of metabolically active sessile cells to reduce a tetrazolium salt (2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide) to water-soluble orange formazan compounds, the intensity of which can then be determined using a microtiter-plate reader. The entire procedure takes approximately 2 d to complete. This technique simplifies biofilm formation and quantification, making it more reliable and comparable among different laboratories, a necessary step toward the standardization of antifungal susceptibility testing of biofilms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772877      PMCID: PMC2741160          DOI: 10.1038/nport.2008.141

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  31 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 2.  Candida biofilms: an update.

Authors:  Gordon Ramage; Stephen P Saville; Derek P Thomas; José L López-Ribot
Journal:  Eukaryot Cell       Date:  2005-04

3.  Integration of Raman microscopy, differential interference contrast microscopy, and attenuated total reflection Fourier transform infrared spectroscopy to investigate chlorhexidine spatial and temporal distribution in Candida albicans biofilms.

Authors:  P A Suci; G G Geesey; B J Tyler
Journal:  J Microbiol Methods       Date:  2001-09       Impact factor: 2.363

4.  Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents.

Authors:  S P Hawser; H Norris; C J Jessup; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

5.  Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

Authors:  G Ramage; K Vande Walle; B L Wickes; J L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 6.  Fungal infections: a growing threat.

Authors:  D M Dixon; M M McNeil; M L Cohen; B G Gellin; J R La Montagne
Journal:  Public Health Rep       Date:  1996 May-Jun       Impact factor: 2.792

7.  Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B.

Authors:  G S Baillie; L J Douglas
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

8.  Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents.

Authors:  G S Baillie; L J Douglas
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

9.  Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars.

Authors:  Ye Jin; Lakshman P Samaranayake; Yuthika Samaranayake; Hak Kong Yip
Journal:  Arch Oral Biol       Date:  2004-10       Impact factor: 2.633

10.  Innovative endpoint determination system for antifungal susceptibility testing of yeasts.

Authors:  R Tellier; M Krajden; G A Grigoriew; I Campbell
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

View more
  279 in total

1.  Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.

Authors:  Priya Uppuluri; Anand Srinivasan; Anand Ramasubramanian; Jose L Lopez-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms.

Authors:  Emeka I Nweze; Adam Ghannoum; Jyotsna Chandra; Mahmoud A Ghannoum; Pranab K Mukherjee
Journal:  J Antimicrob Chemother       Date:  2011-10-11       Impact factor: 5.790

3.  A high-throughput assay of yeast cell lysis for drug discovery and genetic analysis.

Authors:  Louis DiDone; Thomas Scrimale; Bonnie K Baxter; Damian J Krysan
Journal:  Nat Protoc       Date:  2010-05-27       Impact factor: 13.491

4.  Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening.

Authors:  Joe J Harrison; Carol A Stremick; Raymond J Turner; Nick D Allan; Merle E Olson; Howard Ceri
Journal:  Nat Protoc       Date:  2010-06-10       Impact factor: 13.491

5.  The Activities of Adhesion and Biofilm Formation by Candida tropicalis Clinical Isolates Display Significant Correlation with Its Multilocus Sequence Typing.

Authors:  Shuan Bao Yu; Wen Ge Li; Xiao Shu Liu; Jie Che; Jin Xing Lu; Yuan Wu
Journal:  Mycopathologia       Date:  2017-01-13       Impact factor: 2.574

6.  Candidemia by Candida parapsilosis in a neonatal intensive care unit: human and environmental reservoirs, virulence factors, and antifungal susceptibility.

Authors:  Ralciane de Paula Menezes; Sávia Gonçalves de Oliveira Melo; Meliza Arantes Souza Bessa; Felipe Flávio Silva; Priscila Guerino Vilela Alves; Lúcio Borges Araújo; Mário Paulo Amante Penatti; Vânia Olivetti Steffen Abdallah; Denise von Dollinger de Brito Röder; Reginaldo Dos Santos Pedroso
Journal:  Braz J Microbiol       Date:  2020-02-15       Impact factor: 2.476

7.  In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms.

Authors:  Semanti Sarkar; Priya Uppuluri; Christopher G Pierce; Jose L Lopez-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

8.  Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.

Authors:  Laura Judith Marcos-Zambrano; Mireia Puig-Asensio; Felipe Pérez-García; Pilar Escribano; Carlos Sánchez-Carrillo; Oscar Zaragoza; Belén Padilla; Manuel Cuenca-Estrella; Benito Almirante; M Teresa Martín-Gómez; Patricia Muñoz; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

9.  Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41-dependent mechanisms.

Authors:  Mohua Banerjee; Priya Uppuluri; Xiang R Zhao; Patricia L Carlisle; Geethanjali Vipulanandan; Cristina C Villar; José L López-Ribot; David Kadosh
Journal:  Eukaryot Cell       Date:  2012-12-07

10.  Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms.

Authors:  Margarida Martins; Priya Uppuluri; Derek P Thomas; Ian A Cleary; Mariana Henriques; José L Lopez-Ribot; Rosário Oliveira
Journal:  Mycopathologia       Date:  2009-12-13       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.